- Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. Kralovics, R., Sokol, L., Prchal, J.T. J. Clin. Invest. (1998)
- Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Celik, M., Gökmen, N., Erbayraktar, S., Akhisaroglu, M., Konakc, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Cerami, A., Brines, M. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Human hematopoietic progenitors express erythropoietin. Stopka, T., Zivny, J.H., Stopkova, P., Prchal, J.F., Prchal, J.T. Blood (1998)
- Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Stolze, I., Berchner-Pfannschmidt, U., Freitag, P., Wotzlaw, C., Rössler, J., Frede, S., Acker, H., Fandrey, J. Blood (2002)
- Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Hanazono, Y., Chiba, S., Sasaki, K., Mano, H., Yazaki, Y., Hirai, H. Blood (1993)
- Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson, A.M., Jirström, K., Fredlund, E., Nilsson, S., Rydén, L., Landberg, G., Påhlman, S. Clin. Cancer Res. (2009)
- Hepatic erythropoietin gene regulation by GATA-4. Dame, C., Sola, M.C., Lim, K.C., Leach, K.M., Fandrey, J., Ma, Y., Knöpfle, G., Engel, J.D., Bungert, J. J. Biol. Chem. (2004)
- Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. Alghamdi, A.A., Albanna, M.J., Guru, V., Brister, S.J. Journal of cardiac surgery. (2006)
- Erythropoietin in human milk: physiology and role in infant health. Semba, R.D., Juul, S.E. Journal of human lactation : official journal of International Lactation Consultant Association. (2002)
- Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease? Paoletti, E., Cannella, G. J. Am. Soc. Nephrol. (2006)
- Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin. Papavasiliou, E.C., Gouva, C., Siamopoulos, K.C., Tselepis, A.D. Kidney Int. (2005)
- Free radicals in the physiological control of cell function. Dröge, W. Physiol. Rev. (2002)
- Epoetin for severe anemia in hepatoerythropoietic porphyria. Horina, J.H., Wolf, P. N. Engl. J. Med. (2000)
- Erythropoietin for end-stage renal disease. Adamson, J.W., Eschbach, J.W. N. Engl. J. Med. (1998)
- The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. Besarab, A., Bolton, W.K., Browne, J.K., Egrie, J.C., Nissenson, A.R., Okamoto, D.M., Schwab, S.J., Goodkin, D.A. N. Engl. J. Med. (1998)
- Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. Silva, M., Richard, C., Benito, A., Sanz, C., Olalla, I., Fernández-Luna, J.L. N. Engl. J. Med. (1998)
- Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz, D.A., Di, X., Walker, T.D., Sawyer, S.T. Clin. Cancer Res. (2006)
- Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Agani, F., Semenza, G.L. Mol. Pharmacol. (1998)
- Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium. Kimata, H., Yoshida, A., Ishioka, C., Masuda, S., Sasaki, R., Mikawa, H. Clin. Exp. Immunol. (1991)
- Neuroprotective properties of epoetin alfa. Cerami, A., Brines, M., Ghezzi, P., Cerami, C., Itri, L.M. Nephrol. Dial. Transplant. (2002)
- Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol. Ganser, A., Maurer, A., Contzen, C., Seipelt, G., Ottmann, O.G., Schadeck-Gressel, C., Kolbe, K., Haas, R., Zander, C., Reutzel, R., Hoelzer, D. Ann. Hematol. (1996)
- Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Livnah, O., Stura, E.A., Middleton, S.A., Johnson, D.L., Jolliffe, L.K., Wilson, I.A. Science (1999)
- Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. Sato, T., Maekawa, T., Watanabe, S., Tsuji, K., Nakahata, T. J. Clin. Invest. (2000)
- Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Rabinowitz, J., Petros, W.P., Stuart, A.R., Peters, W.P. Blood (1993)
- Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors. van den Akker, E., van Dijk, T., Parren-van Amelsvoort, M., Grossmann, K.S., Schaeper, U., Toney-Earley, K., Waltz, S.E., Löwenberg, B., von Lindern, M. Blood (2004)
- Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Boer, A.K., Drayer, A.L., Rui, H., Vellenga, E. Blood (2002)
- A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line. Kirito, K., Uchida, M., Takatoku, M., Nakajima, K., Hirano, T., Miura, Y., Komatsu, N. Blood (1998)
- Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Beleslin-Cokic, B.B., Cokic, V.P., Yu, X., Weksler, B.B., Schechter, A.N., Noguchi, C.T. Blood (2004)
- Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Galeano, M., Altavilla, D., Bitto, A., Minutoli, L., Calò, M., Cascio, P.L., Polito, F., Giugliano, G., Squadrito, G., Mioni, C., Giuliani, D., Venuti, F.S., Squadrito, F. Crit. Care Med. (2006)
- Biology of erythropoietin. Lacombe, C., Mayeux, P. Haematologica (1998)
- The cytokine receptor gp130: faithfully promiscuous. Müller-Newen, G. Sci. STKE (2003)
- Erythropoietin: physiology and pharmacology update. Fisher, J.W. Exp. Biol. Med. (Maywood) (2003)
- Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. Wang, F., Zhang, R., Beischlag, T.V., Muchardt, C., Yaniv, M., Hankinson, O. J. Biol. Chem. (2004)
- Expression of the erythropoietin receptor by trophoblast cellsin the human placenta. Fairchild Benyo, D., Conrad, K.P. Biol. Reprod. (1999)
- Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. Verdier, F., Chrétien, S., Billat, C., Gisselbrecht, S., Lacombe, C., Mayeux, P. J. Biol. Chem. (1997)
- Involvement of the Src kinase Lyn in phospholipase C-gamma 2 phosphorylation and phosphatidylinositol 3-kinase activation in Epo signalling. Boudot, C., Dassé, E., Lambert, E., Kadri, Z., Mayeux, P., Chrétien, S., Haye, B., Billat, C., Petitfrère, E. Biochem. Biophys. Res. Commun. (2003)
- Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells. Torti, M., Marti, K.B., Altschuler, D., Yamamoto, K., Lapetina, E.G. J. Biol. Chem. (1992)
- Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Faquin, W.C., Schneider, T.J., Goldberg, M.A. Blood (1992)
- Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Lecoq-Lafon, C., Verdier, F., Fichelson, S., Chrétien, S., Gisselbrecht, S., Lacombe, C., Mayeux, P. Blood (1999)
- Evidence against a major role for Ca2+ in hypoxia-induced gene expression in human hepatoma cells (Hep3B). Metzen, E., Fandrey, J., Jelkmann, W. J. Physiol. (Lond.) (1999)
- Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. Wakao, H., Harada, N., Kitamura, T., Mui, A.L., Miyajima, A. EMBO J. (1995)
- An essential role for p300/CBP in the cellular response to hypoxia. Arany, Z., Huang, L.E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M.A., Bunn, H.F., Livingston, D.M. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Carow, C.E., Hangoc, G., Cooper, S.H., Williams, D.E., Broxmeyer, H.E. Blood (1991)
- NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1. Osada, M., Imaoka, S., Sugimoto, T., Hiroi, T., Funae, Y. J. Biol. Chem. (2002)
- Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Lai, S.Y., Childs, E.E., Xi, S., Coppelli, F.M., Gooding, W.E., Wells, A., Ferris, R.L., Grandis, J.R. Oncogene (2005)
- Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. Sun, Y., Zhou, C., Polk, P., Nanda, A., Zhang, J.H. J. Cereb. Blood Flow Metab. (2004)